| 6824972 |
Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-&kgr;B) activation |
Sue J. Kenwrick, Hayley Woffendin, Arnold Munnich, Asmae Smahi, Alain Israel +6 more |
2004-11-30 |
|
| 6638936 |
Benzofurylpiperazine serotonin agonists |
Karin Briner, Timothy Paul Burkholder, Mark L. Heiman |
2003-10-28 |
$145,966,000 |
| 6180337 |
Diagnosis of the fragile X syndrome |
C. Thomas Caskey, Maura Pieretti, Stephen Warren, Ben A. Oostra, Ying-Hui Fu |
2001-01-30 |
|
| 6107025 |
Diagnosis of the fragile X syndrome |
C. Thomas Caskey, Maura Pieretti, Stephen Warren, Ben A. Oostra |
2000-08-22 |
|
| 6090945 |
Tetrahydro-beta-carbolines |
James E. Audia |
2000-07-18 |
$169,901,000 |
| 5886004 |
Tetrahydrobetacarboline compounds |
James E. Audia |
1999-03-23 |
$193,051,000 |
| 5869497 |
Method of treating or ameliorating the symptoms of common cold or allergic rhinitis |
Kirk Willis Johnson, Lee A. Phebus |
1999-02-09 |
$405,738,000 |
| 5861425 |
Indole-ethanamines |
James E. Audia, James J. Droste, Gwyn L. Murdoch |
1999-01-19 |
$131,662,000 |
| 5760051 |
Tetrahydro-beta-carbolines |
James E. Audia, James J. Droste, Deborah A. Evrard, Pawel Fludzinski, Gwyn L. Murdoch |
1998-06-02 |
$99,031,000 |
| 5736544 |
Naphthylpiperazinyl compounds useful for treating 5HT.sub.2B receptor mediated conditions |
James E. Audia, Marlene L. Cohen, Jaswant S. Gidda |
1998-04-07 |
$166,503,000 |
| 5705519 |
Method for treating 5-HT.sub.2B receptor related conditions |
James E. Audia, Marlene L. Cohen, Jaswant S. Gidda |
1998-01-06 |
$98,435,000 |
| 5688807 |
Method for treating 5HT.sub.2B receptor related conditions |
James E. Audia, Marlene L. Cohen, Jaswant S. Gidda |
1997-11-18 |
$88,547,000 |
| 5674875 |
Method of blocking human 5-hydroxytryptamine-2 receptors |
Marlene L. Cohen |
1997-10-07 |
$90,547,000 |
| 5635528 |
Intermediates to tetrahydro-beta-carbolines |
James E. Audia, James J. Droste, Deborah A. Evrard, Pawel Fludzinski, Gwyn L. Murdoch |
1997-06-03 |
$63,604,000 |
| 5556947 |
Monoclonal antibody recognizing a surface molecule on a subset of antigen-stimulated T cells and on certain malignancies of T and B cell origin |
Glenn H. Bock, Carole C. Kurman, Thomas A. Fleisher |
1996-09-17 |
|
| 5508284 |
Tetrahydro-beta-carbolines |
James E. Audia, James J. Droste, Deborah A. Evrard, Pawel Fludzinski, Gwyn L. Murdoch |
1996-04-16 |
$37,524,000 |
| 5500431 |
Tetrahydro-.beta.-carbolines |
James E. Audia, James J. Droste, Deborah A. Evrard, Pawel Fludzinski, Gwyn L. Murdoch |
1996-03-19 |
$123,161,000 |
| 5457101 |
Thieno[1,5]benzoidiazepine use |
Beverley Greenwood |
1995-10-10 |
$13,063,000 |
